ABSTRACT NUMBER: ESOC2026LT17 LT17 - THE EFFICACY OF COLCHICINE FOR SECONDARY PREVENTION AFTER STROKE ACCORDING TO THE PRESENCE OF ATHEROSCLEROSIS: A SECONDARY ANALYSIS OF THE CONVINCE TRIAL.
John McCabe, Sarah Coveney, Urs Fischer, Ana Catarina Fonseca, Christina Kruuse, Robin Lemmens, Francisco Purroy, Chris Price, Christian Weimar, Peter Kelly · 2026
Read ABSTRACT NUMBER: ESOC2026LT17 LT17 - THE EFFICACY OF COLCHICINE FOR SECONDARY PREVENTION AFTER STROKE ACCORDING TO THE PRESENCE OF ATHEROSCLEROSIS: A SECONDARY ANALYSIS OF THE CONVINCE TRIAL. by John McCabe, Sarah Coveney, Urs Fischer, Ana Catarina Fonseca, Christina Kruuse, Robin Lemmens, Francisco Purroy, Chris Price, Christian Weimar, Peter Kelly (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145851.txt.
Description
John McCabe and co-authors re-analyze a stroke prevention trial in a 2026 conference report. The CONVINCE trial tested colchicine, an anti-inflammatory drug, added to usual care after stroke. The open question was whether any benefit belongs only to patients whose arteries show atherosclerosis, the fatty buildup that drives many strokes. The team split trial members by that trait.
The trial held more than three thousand patients, followed for close to three years. In the group with artery buildup, major events such as repeat stroke or heart events were somewhat fewer on the drug, but the gap did not reach clear significance. The no-buildup group saw no difference. Among patients who stayed on treatment, the drug did cut events in the buildup group. The authors suggest future anti-inflammatory trials should require artery buildup for entry.
Catalog record
| CREATOR | John McCabe, Sarah Coveney, Urs Fischer, Ana Catarina Fonseca, Christina Kruuse, Robin Lemmens, Francisco Purroy, Chris Price, Christian Weimar, Peter Kelly |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |